Brief: Nuvectis Pharma Announces Upcoming Presentations For Nxp900 At The 2026 American Association
31/03/2026 13:31
March 31 (Reuters) - Nuvectis Pharma Inc NVCT.O: NUVECTIS PHARMA ANNOUNCES UPCOMING PRESENTATIONS FOR NXP900 AT THE 2026 AMERICAN ASSOCIATION FOR CANCER RESEARCH MEETING Source text: ID:nGNX2N59Kd Further company coverage: NVCT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nuvectis Pharma
See all newsNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Ciprocopan (NXP100) Receives Marketing Approval In China For The Treatment Of Patients With PNH Previously Untreated With Complement Inhibitors
U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin